NEW YORK (GenomeWeb News) – Fluidigm and Life Technologies' Applied Biosystems business have agreed to end legal actions against each other related to Fluidigm's BioMark System, a Fluidigm spokesperson told GenomeWeb Daily Newstoday.

The firms agreed to dismiss the case, which was filed by Fluidigm against ABI in June 2008, last week, according to court documents. Howard High, the Fluidigm spokesman, told GWDN that the agreement does not include the exchange of any money or any licensing of products.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

The Atlantic reports that genetic counselors are coping with an influx of patients seeking advice on their direct-to-consumer genetic test results.

A small study finds differences between three genomic prostate cancer tests, Medscape reports.

In Nature this week: shared genetic architecture for asthma and allergic diseases, and more.

A survey of Canadians finds them to be divided on genetically modified food, the Ottawa Citizen reports.

Jun
19
Sponsored by
Advanced Cell Diagnostics

This webinar will provide evidence for the use of RNA in situ hybridization (RNA ISH) as a replacement for immunohistochemistry (IHC) in cancer research and diagnostic applications.

Jun
21
Sponsored by
Roche

This webinar will provide a detailed look at how a genomics lab implemented next-generation sequencing (NGS) liquid biopsy assays into its in-house clinical research program.